Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Protagonist Therapeutics Inc | 1,020,333 | 939,669 | -80,664 | $39.38M | $45.44M | 8.74% | +$6.06M |
| Ea Series TrustALPHA ARCH 1 3 ALPHA ARCH 1-3 | 325,450 | 337,125 | +11,675 | $35.89M | $37.59M | 7.23% | +$1.70M |
| Roivant Sciences Ltd.SHS(ROIV) | 3,508,694 | 3,483,404 | -25,290 | $41.51M | $35.15M | 6.76% | -$6.36M |
| Zai Lab LimitedADR(ZLAB) | 1,045,837 | 940,858 | -104,979 | $27.39M | $34.00M | 6.54% | +$6.61M |
| Immunovant, Inc.(IMVT) | 787,478 | 968,866 | +181,388 | $19.51M | $16.56M | 3.19% | -$2.95M |
| Cytokinetics, Incorporated(CYTK) | 414,209 | 390,729 | -23,480 | $19.48M | $15.70M | 3.02% | -$3.78M |
| Keros Therapeutics, Inc.(KROS) | 23,246 | 1,486,461 | +1,463,215 | $368.0K | $15.15M | 2.91% | +$14.78M |
| ABIVAX Société AnonymeADS(ABVX) | 1,513,393 | 2,210,019 | +696,626 | $11.08M | $13.81M | 2.66% | +$2.73M |
| Spdr Ser TrBLOOMBERG 1 3 MO ST STR BLO 1 ETF | 131,786 | 135,585 | +3,799 | $12.05M | $12.44M | 2.39% | +$388.0K |
| BridgeBio Pharma, Inc.(BBIO) | 678,857 | 339,635 | -339,222 | $18.63M | $11.74M | 2.26% | -$6.89M |
| Inhibikase Therapeutics, Inc.(IKT) | 5,103,005 | 5,122,105 | +19,100 | $16.58M | $11.22M | 2.16% | -$5.37M |
| Springworks Therapeutics Inc | 0 | 207,778 | +207,778 | $0 | $9.17M | 1.76% | +$9.17M |
| Ishares Tr1 3 YR TREAS BD | 0 | 103,337 | +103,337 | $0 | $8.55M | 1.64% | +$8.55M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 146,671 | 523,767 | +377,096 | $3.23M | $8.05M | 1.55% | +$4.82M |
| Sarepta Therapeutics, Inc.(SRPT) | 40,002 | 122,921 | +82,919 | $4.86M | $7.84M | 1.51% | +$2.98M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.63M | $7.72M | 1.49% | +$90.0K |
| CG Oncology, Inc.(CGON) | 215,750 | 301,134 | +85,384 | $6.19M | $7.37M | 1.42% | +$1.19M |
| Rapt Therapeutics Inc | 1,174,313 | 5,970,768 | +4,796,455 | $1.86M | $7.28M | 1.40% | +$5.43M |
| Arbutus Biopharma Corporation(ABUS) | 1,554,802 | 1,879,114 | +324,312 | $5.08M | $6.56M | 1.26% | +$1.47M |
| Intra-Cellular Therapies Inc | 0 | 48,044 | +48,044 | $0 | $6.34M | 1.22% | +$6.34M |
| Revolution Medicines, Inc.(RVMD) | 170,000 | 177,136 | +7,136 | $7.44M | $6.26M | 1.21% | -$1.17M |
| Anteris Technologies Global Corp.(AVR) | 1,052,968 | 1,678,063 | +625,095 | $5.88M | $6.11M | 1.18% | +$232.6K |
| Aa Mission Acquisition CorpCL A | 560,199 | 578,359 | +18,160 | $5.66M | $6.03M | 1.16% | +$374.3K |
| Sage Therapeutics Inc | 19,200 | 742,495 | +723,295 | $104.3K | $5.90M | 1.14% | +$5.80M |
| 89bio Inc | 515,138 | 804,220 | +289,082 | $4.03M | $5.85M | 1.12% | +$1.82M |
| Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS) | 0 | 0 | 0 | $5.48M | $5.48M | 1.06% | +$6.8K |
| Oaktree Acquisition Corp IiiUNIT 10 04 2029 UNIT 10/04/2029 | 500,000 | 516,482 | +16,482 | $5.07M | $5.39M | 1.04% | +$327.1K |
| Helix Acquisition Corp IiCL A | 404,138 | 469,729 | +65,591 | $4.24M | $5.31M | 1.02% | +$1.06M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 1,471,587 | +1,471,587 | $0 | $5.21M | 1.00% | +$5.21M |
| Scholar Rock Holding Corporation(SRRK) | 19,505 | 157,079 | +137,574 | $843.0K | $5.05M | 0.97% | +$4.21M |
| Xenon Pharmaceuticals Inc.(XENE) | 50,547 | 127,548 | +77,001 | $1.98M | $4.28M | 0.82% | +$2.30M |
| Xencor, Inc.(XNCR) | 234,607 | 398,152 | +163,545 | $5.39M | $4.24M | 0.82% | -$1.15M |
| Mineralys Therapeutics, Inc.(MLYS) | 841,541 | 263,425 | -578,116 | $10.36M | $4.18M | 0.80% | -$6.18M |
| Septerna, Inc.(SEPN) | 0 | 720,848 | +720,848 | $0 | $4.17M | 0.80% | +$4.17M |
| Janux Therapeutics, Inc.(JANX) | 31,509 | 153,767 | +122,258 | $1.69M | $4.15M | 0.80% | +$2.46M |
| BridgeBio Pharma, Inc.NOTE 2 250 2 0(BBIO) | 0 | 0 | 0 | $3.86M | $4.03M | 0.78% | +$173.3K |
| Apogee Therapeutics Inc | 41,274 | 104,853 | +63,579 | $1.87M | $3.92M | 0.75% | +$2.05M |
| Savara Inc.(SVRA) | 988,468 | 1,360,291 | +371,823 | $3.03M | $3.77M | 0.73% | +$733.4K |
| Monopar Therapeutics Inc.(MNPR) | 130,037 | 100,774 | -29,263 | $2.86M | $3.67M | 0.71% | +$808.4K |
| Aerovate Therapeutics Inc | 928,016 | 1,461,234 | +533,218 | $2.46M | $3.67M | 0.71% | +$1.21M |
| BioAge Labs, Inc.(BIOA) | 123,037 | 971,100 | +848,063 | $712.4K | $3.65M | 0.70% | +$2.94M |
| Zura Bio LimitedCL A(ZURA) | 2,077,251 | 2,801,184 | +723,933 | $5.19M | $3.61M | 0.70% | -$1.58M |
| Astria Therapeutics Inc | 90,984 | 641,690 | +550,706 | $813.4K | $3.43M | 0.66% | +$2.61M |
| Rezolute, Inc.(RZLT) | 1,359,208 | 1,116,047 | -243,161 | $6.66M | $3.24M | 0.62% | -$3.42M |
| Centessa Pharmaceuticals PlcADS | 154,027 | 216,166 | +62,139 | $2.58M | $3.11M | 0.60% | +$528.5K |
| Akero Therapeutics Inc | 15,307 | 71,143 | +55,836 | $425.8K | $2.88M | 0.55% | +$2.45M |
| Merus N V | 81,460 | 66,960 | -14,500 | $3.43M | $2.82M | 0.54% | -$607.0K |
| Bridgebio Pharma IncNOTE 1 750 3 0 | 0 | 0 | 0 | $0 | $2.74M | 0.53% | +$2.74M |
| PTC Therapeutics, Inc.(PTCT) | 48,023 | 50,023 | +2,000 | $2.17M | $2.55M | 0.49% | +$381.4K |
| REGENXBIO Inc.(RGNX) | 170,129 | 350,352 | +180,223 | $1.32M | $2.51M | 0.48% | +$1.19M |
| Ardelyx Inc | 31,035 | 490,743 | +459,708 | $157.3K | $2.41M | 0.46% | +$2.25M |
| BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO) | 0 | 0 | 0 | $2.10M | $2.28M | 0.44% | +$177.7K |
| Dynavax Technologies Corp | 0 | 170,000 | +170,000 | $0 | $2.20M | 0.42% | +$2.20M |
| Arvinas, Inc.(ARVN) | 0 | 313,354 | +313,354 | $0 | $2.20M | 0.42% | +$2.20M |
| A Spac Iii Acquisition CorpCL A ORD SHS CL A | 0 | 215,000 | +215,000 | $0 | $2.16M | 0.42% | +$2.16M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 30,941 | 36,890 | +5,949 | $1.73M | $1.95M | 0.38% | +$222.0K |
| Delcath Systems, Inc.(DCTH) | 149,385 | 149,385 | 0 | $1.80M | $1.90M | 0.37% | +$103.1K |
| Crinetics Pharmaceuticals In | 53,125 | 53,125 | 0 | $2.72M | $1.78M | 0.34% | -$934.5K |
| KALA BIO, Inc.(KALA) | 220,373 | 298,955 | +78,582 | $1.53M | $1.71M | 0.33% | +$183.6K |
| Vir Biotechnology, Inc.(VIR) | 64,067 | 250,000 | +185,933 | $470.3K | $1.62M | 0.31% | +$1.15M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 211,400 | 241,800 | +30,400 | $2.66M | $1.61M | 0.31% | -$1.04M |
| Taysha Gene Therapies, Inc.(TSHA) | 177,707 | 1,066,309 | +888,602 | $307.4K | $1.48M | 0.29% | +$1.17M |
| Viking Therapeutics, Inc.(VKTX) | 9,300 | 59,413 | +50,113 | $374.2K | $1.43M | 0.28% | +$1.06M |
| Fulcrum Therapeutics, Inc.(FULC) | 196,248 | 490,532 | +294,284 | $922.4K | $1.41M | 0.27% | +$490.4K |
| Cargo Therapeutics Inc | 0 | 341,515 | +341,515 | $0 | $1.39M | 0.27% | +$1.39M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 132,780 | +132,780 | $0 | $1.36M | 0.26% | +$1.36M |
| Soleno Therapeutics Inc | 36,830 | 18,830 | -18,000 | $1.66M | $1.35M | 0.26% | -$310.1K |
| Verona Pharma PlcADS | 29,100 | 20,000 | -9,100 | $1.35M | $1.27M | 0.24% | -$81.6K |
| Checkpoint Therapeutics Inc | 0 | 305,800 | +305,800 | $0 | $1.24M | 0.24% | +$1.24M |
| Aldeyra Therapeutics, Inc.(ALDX) | 647,960 | 211,579 | -436,381 | $3.23M | $1.22M | 0.23% | -$2.02M |
| Korro Bio, Inc.(KRRO) | 57,978 | 68,715 | +10,737 | $2.21M | $1.20M | 0.23% | -$1.01M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 82,234 | 168,765 | +86,531 | $1.20M | $1.18M | 0.23% | -$26.7K |
| Tectonic Therapeutic, Inc.(TECX) | 58,708 | 62,603 | +3,895 | $2.71M | $1.11M | 0.21% | -$1.60M |
| Viridian Therapeutics, Inc.(VRDN) | 26,000 | 79,000 | +53,000 | $498.4K | $1.06M | 0.20% | +$566.5K |
| Vistagen Therapeutics, Inc.(VTGN) | 121,461 | 420,765 | +299,304 | $358.3K | $1.05M | 0.20% | +$693.6K |
| Pfizer Inc.(PFE) | 35,050 | 41,050 | +6,000 | $929.9K | $1.04M | 0.20% | +$110.3K |
| Ares Acquisition Corp IiCL A | 138,966 | 90,466 | -48,500 | $1.53M | $1.01M | 0.19% | -$517.2K |
| Surgery Partners, Inc.(SGRY) | 0 | 40,000 | +40,000 | $0 | $950.0K | 0.18% | +$950.0K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 166,406 | 41,412 | -124,994 | $3.29M | $919.8K | 0.18% | -$2.37M |
| Arcellx Inc COMMON STOCK | 3,962 | 13,962 | +10,000 | $303.8K | $915.9K | 0.18% | +$612.1K |
| Regeneron Pharmaceuticals, Inc.(REGN) | 1,361 | 1,361 | 0 | $969.5K | $863.2K | 0.17% | -$106.3K |
| Keen Vision Acquisition CorporationUNIT 99 99 9999(KVACF) | 75,000 | 75,000 | 0 | $824.3K | $841.5K | 0.16% | +$17.3K |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 27,900 | +27,900 | $0 | $817.5K | 0.16% | +$817.5K |
| Grace Therapeutics, Inc.(GRCE) | 773,635 | 343,512 | -430,123 | $2.89M | $783.2K | 0.15% | -$2.11M |
| Kezar Life Sciences Inc COM NEW | 147,404 | 147,404 | 0 | $990.6K | $719.3K | 0.14% | -$271.2K |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 12,900 | 56,300 | +43,400 | $242.5K | $717.3K | 0.14% | +$474.7K |
| Structure Therapeutics IncADS | 35,319 | 35,619 | +300 | $957.9K | $616.6K | 0.12% | -$341.3K |
| Biogen Inc.(BIIB) | 3,045 | 4,500 | +1,455 | $465.6K | $615.8K | 0.12% | +$150.1K |
| Iteos Therapeutics Inc | 131,599 | 101,096 | -30,503 | $1.01M | $603.5K | 0.12% | -$407.1K |
| Natera, Inc.(NTRA) | 0 | 4,250 | +4,250 | $0 | $601.0K | 0.12% | +$601.0K |
| Zymeworks Inc.(ZYME) | 0 | 50,000 | +50,000 | $0 | $595.5K | 0.11% | +$595.5K |
| Lexeo Therapeutics, Inc.(LXEO) | 169,505 | 170,448 | +943 | $1.12M | $591.5K | 0.11% | -$523.9K |
| Kiora Pharmaceuticals, Inc.(KPRX) | 200,221 | 194,665 | -5,556 | $660.7K | $585.9K | 0.11% | -$74.8K |
| Spero Therapeutics, Inc.(SPRO) | 801,277 | 801,277 | 0 | $825.3K | $576.9K | 0.11% | -$248.4K |
| Biohaven Ltd.(BHVN) | 0 | 22,641 | +22,641 | $0 | $544.3K | 0.10% | +$544.3K |
| Protara Therapeutics, Inc.(TARA) | 122,690 | 122,690 | 0 | $647.8K | $522.7K | 0.10% | -$125.1K |
| WisdomTree, Inc.FLOATNG RAT TREA(WT) | 10,000 | 10,000 | 0 | $503.2K | $503.3K | 0.10% | +$100 |
| Agriculture & Nat Sol Acq CoCL A SHS CL A | 80,362 | 47,062 | -33,300 | $843.0K | $502.1K | 0.10% | -$340.9K |
| Eli Lilly and Company(LLY) | 1,350 | 600 | -750 | $1.04M | $495.5K | 0.10% | -$546.7K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 1,490 | +1,490 | $0 | $493.5K | 0.09% | +$493.5K |